“No Man Left Behind”: American Technology Ships with Our Values - Andreessen Horowitz
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
This article is an excerpt. To read the full content, visit the original source. Andreessen Horowitz
Related articles

Core values: the Austrian scheme bringing forgotten apple varieties back to life - The Guardian
Only about 10 of the 2,000 types of apples growing in Austria can be found in supermarkets among the polished, pristine fruit usually on display – a sad ratio according to fans of historic varieties being primed for a comeback. One of the country’s biggest retail chains has embarked on a pilot rollout of unusual and long-forgotten apples enjoyed in previous centuries, riding an international trend of reviving heirloom fruit and vegetables. The Spar group is working with produce distributor Frutura to return two rare varieties to shops: Ilzer Rosenapfel (Ilzer Rose apple), dating from about 1840 from the southern state of Styria, and Falchs Gulderling, identified in the 1870s in South Tirol. “Farming never stands still,” said Frutura co-managing director Katrin Hohensinner-Häupl, calling it a dance between knowledge passed down through generations and innovation. Rediscovering antique apples using modern cultivation methods are “bringing their history and flavour back to life,” she said.

RTX 5060, Ryzen 7 5700X gaming PC drops to competitive price with Newegg deal — its lowest in 30 days - PC Guide
There's extra savings to be had on top of the deal, too PC Guide is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Read More

Combination nucleic acid therapies: towards personalized cancer treatment - Advanced Science News
Combination strategies enable simultaneous activation and silencing of key target genes to correct molecular pathways in pancreatic cancer. For the first time, scientists have designed combination therapies of small nucleic acid therapeutics based on the specific molecular characteristics of a tumor. These novel therapies work in an opposite but complementary way to regulate gene expression. This innovative approach, tested in pre-clinical models of pancreatic ductal adenocarcinoma (PDAC), shows superior anti-cancer effects compared to single nucleic acid therapies, offering the potential of flexible, precise, and personalized cancer treatments.
0 comments
No comments yet. Be the first to share your thoughts!